Catalog |
name |
Description |
price |
R-Mcs-041 |
PS:NBD-lipid (99:1 molar ratio) |
The PS:NBD-lipid/L-alpha-phosphatidylserine:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) (99:1 molar ratio) combines the functional properties of phosphatidylserine with the tracking capabilities of NBD, making it suitable for various applications in drug delivery, cell biology, and biophysical research. |
price> |
R-Mcs-042 |
PS:PC:NBD-lipid |
The PS:PC:NBD-lipid/L-alpha-phosphatidylserine:L-alpha-phosphatidylcholine:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE) combines the beneficial properties of phosphatidylserine and phosphatidylcholine with the capacity for fluorescence labeling provided by the NBD-lipid. This combination is particularly useful in the fields of drug delivery, cell biology, and biophysics, facilitating a broad range of experimental and therapeutic applications. |
price> |
R-M1-8762 |
LNP-cy5/RGD,100nm |
Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy).
|
price> |
R-M1-8763 |
FITC-Ti3C2,200nm-1000nm |
FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities. |
price> |
R-M1-cs8773 |
CY7@EScu@ROSlnp-YSAYPDSVPMMS |
ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments. |
price> |
R-M1-cs8774 |
Cyanine7@ES@ROSlnp-YSAYPDSVPMMS |
ROS responsive liposome nanoparticles encapsulate ES and CY7 surface modified peptides.By encapsulating ES and CY7 surface-modified peptides within the ROS-responsive liposome nanoparticles, it is possible to achieve targeted delivery or imaging in ROS-rich environments. The surface modifications on the peptides can facilitate specific interactions with the target cells or tissues, while the ROS-responsive nature of the liposomes regulates the release of the peptides in response to the local ROS levels. |
price> |
R-M1-cs8799 |
ROS responsive liposomes loaded with CE6 |
ROS responsive liposomes loaded with CE6 (chlorin e6) are a type of drug delivery system designed to specifically target and respond to reactive oxygen species (ROS) in the body.
Upon destabilization, the liposomes release the CE6 into the surrounding tissues. The released CE6 can then undergo a photochemical reaction when activated by specific wavelengths of light, generating highly reactive singlet oxygen species. This localized generation of singlet oxygen can induce cell death, making it particularly suitable for photodynamic therapy (PDT) applications.
By specifically targeting and releasing the CE6 in ROS-rich areas, ROS responsive liposomes loaded with CE6 can enhance the therapeutic efficacy of photodynamic therapy while minimizing off-target effects. |
price> |
R-M1-9151 |
Cy5-azide modified SiO2,800nm |
Cy5-azide modified SiO2 refers to silicon dioxide (SiO2) nanoparticles that have been modified with the organic dye Cy5 and functionalized with an azide group.It could be used in applications such as fluorescent imaging, drug delivery, or bioconjugation, where the azide group can participate in specific chemical reactions to link the modified nanoparticles to other functional molecules or surfaces. |
price> |
R-M1-9169 |
Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin |
Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin/Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin from ruixi.We can accept customized products.
Ce6: This likely refers to Chlorin e6, a photosensitizer used in photodynamic therapy (PDT) for the treatment of cancer. Ce6 absorbs light and transfers energy to molecular oxygen, creating reactive oxygen species that can destroy nearby cancer cells.
Polydopamine: This is a biocompatible and adhesive polymer derived from dopamine. It has been used as a coating material for drug delivery systems due to its versatile surface functionalization and biocompatibility.
MIL-101: This is a metal-organic framework (MOF), a class of materials with high porosity and surface area. MIL-101 can be used to encapsulate and deliver drugs due to its porous nature and controllable pore sizes.
Gemcitabine: It is a chemotherapy medication used to treat various types of cancers, including bladder cancer, breast cancer, ovarian cancer, and non-small cell lung cancer.
Cisplatin: This is a chemotherapy medication used to treat various types of cancers, including testicular, ovarian, bladder, and lung cancers. |
price> |
R-M2cs-9466 |
FITC and Concanavalin A-PAMAM G5 microspheres@Cannabinoids |
The applications of FITC and Concanavalin A-PAMAM G5 microspheres @Cannabinoids:
Targeted Drug Delivery:
The FITC labeling allows for easy tracking of the delivery system in biological studies, while Con A provides the capability to target cells specifically expressing carbohydrates.Encapsulation of cannabinoids could enhance their delivery to target tissues, potentially for pain management, anti-inflammatory effects, and more.
Diagnostics:
FITC-modified microspheres could be used in assays or imaging techniques to detect the presence of specific glycoproteins or cells in the sample.
Research Tools:
The combination of fluorescent tagging and carbohydrate-targeting capability could be utilized in research applications, enabling the study of cannabinoid uptake in various cell types.
Therapeutic Applications:
This system could facilitate improved therapies for various conditions where cannabinoids are known to have beneficial effects, tailoring the delivery to affected tissue types. |
price> |